National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 14520 [2014-05677]

Download as PDF 14520 Federal Register / Vol. 79, No. 50 / Friday, March 14, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Office of the Director, National Institutes of Health; Notice of Meeting National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee to the Director, National Institutes of Health (ACD). The meeting is virtual and open to the public. The HeLa Genome Data Access working group will present a summary of its assessment of requests to access HeLa cell genome sequence data in the NIH database of Genotype and Phenotype (dbGaP). The HeLa Genome Data Access working group report, as well as instructions for joining the virtual meeting, will be posted when available on the ACD Web site (https:// acd.od.nih.gov). Additional information about the HeLa Genome Data Access working group can be accessed at https://acd.od.nih.gov/hegda.htm. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Review of Career Development (K) Applications. Date: March 18, 2014. Time: 2:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Raul A. Saavedra, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS, NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892– 9529, 301–496–9223, saavedrr@ ninds.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS). sroberts on DSK5SPTVN1PROD with NOTICES Dated: March 11, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–05677 Filed 3–13–14; 8:45 am] BILLING CODE 4140–01–P Name of Committee: Advisory Committee to the Director, National Institutes of Health. Date: March 28, 2014. Time: 10:00 a.m. to 2:00 p.m. Eastern Time. Agenda: Presentation and discussion of the HeLA Genome Data Access Working Group Report. Time 2:00 p.m. to 6:00 p.m. Eastern Time. Agenda: Voting by ACD Members on Requests for Access to HeLa Genome Sequence Data. Place: Virtual Meeting, Accessible at the following Web site: https://helaacd.nih.gov/ access-requests/march-2014/. Contact Information: Gretchen S. Wood, Staff Assistant, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, Maryland 20892–0148, Telephone: 301–496–4272, woodgs@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person and must be sent by 5:00 p.m. Eastern Time on March 25, 2014. Statements will be posted on the ACD Web site and made accessible during this virtual meeting. Dated: March 10, 2014. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2014–05538 Filed 3–13–14; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 19:18 Mar 13, 2014 Jkt 232001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel ‘‘NIAID Investigator Initiated Program Project Applications (P01)’’. Date: April 8, 2014. Time: 1:00 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 3251, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Richard W. Morris, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700–B Rockledge Drive, MSC–7616, Room 3251, Bethesda, MD 20892–7616, 301–451–2663, rmorris@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Integrated Preclinical/ Clinical Program for HIV Microbicides and Biomedical Prevention (IPCP–MBP) (U19). Date: April 9–10, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, (Formerly Holiday Inn Select), Ballroom A&B, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Betty Poon, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–6891, poonb@mail.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel ‘‘Innovative Assays to Quantify the Latent HIV Reservoir (R21)’’. Date: April 9, 2014. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3117, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). E:\FR\FM\14MRN1.SGM 14MRN1

Agencies

[Federal Register Volume 79, Number 50 (Friday, March 14, 2014)]
[Notices]
[Page 14520]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05677]



[[Page 14520]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Review of Career Development (K) 
Applications.
    Date: March 18, 2014.
    Time: 2:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Raul A. Saavedra, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS, NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC 9529, 
Bethesda, MD 20892-9529, 301-496-9223, saavedrr@ninds.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS).

    Dated: March 11, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-05677 Filed 3-13-14; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.